Taking It to the Next Level
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Symbols Alexian Brothers Health System Index to Nov P
Volume 19, Index December 2014 Symbols Alexian Brothers Health System Index to Nov p. 2 Health Care M&A News 1-800-CONTACTS Feb p. 18 A&L Goodbody Apr p. 16, July p. 16 All Care Home Health, LLC Feb p. 17 Each company and orga- A Allergan Inc. Feb p. 10, May p. 1, nization discussed in Health May p. 19, Jun p. 15, July p. 3, Care M&A News, from Janu- Abbott Labs July p. 3, Aug p. 17, July p. 10, Sept p. 16, Oct p. 3, ary through December 2014, Dec p. 4 Nov p. 1, Dec p. 4, Dec p. 16, is listed alphabetically here. AbbVie Inc. July p. 3, July p. 16, Dec p. 19 References are typically to Aug p. 9, Oct p. 2, Oct p. 16, Allscripts Feb p. 2, Apr p. 10 the first occurrence of the Nov p. 19, Dec p. 2 AllSpire Health Partners Nov p. 2 company’s or organiza- ABL, Inc. Aug p. 18 All Staffing Services Jan p. 17 tion’s name in the pertinent Acadia Healthcare Company Feb p. 16, Almost Family, Inc. Apr p. 16 issue; further discussion July p. 17, Oct p. 17, Nov p. 17 ALN Medical Management, LLC may follow later in the text Accelera Innovations, Inc. Jan p. 17 Accelrys, Inc. Jan p. 15 Feb p. 8 but is not indicated here. AccessClosure, Inc. May p. 15 Alta Partners Jun p. 16 Achillion Pharmaceuticals July p. 17 Altos Solutions, Inc. Jun p. 15 References are sorted by Actavis (Foshan) Pharmaceuticals Co. -
Press Release Results As at 31 December 2020
PRESS RELEASE RESULTS AS AT 31 DECEMBER 2020 • PROFIT NET OF COSTS RELATED TO THE VOLUNTARY REDUNDANCY PLAN AND THE CLOSURE OF 300 BRANCHES AS WELL AS OTHER NON-RECURRING COMPONENTS1: € 330 MILLION • PROPOSED DISTRIBUTION OF A DIVIDEND OF 6 CENTS PER SHARE, IN LINE WITH ECB GUIDELINES PROFIT FROM OPERATIONS2 AT € 1,722 MILLION: • ESSENTIALLY STABLE (-1.4%) WITH RESPECT TO 2019, DESPITE THE NEGATIVE EFFECTS OF THE PANDEMIC CRISIS WHICH EXPLODED AT THE START OF 2020 AND IS STILL ONGOING; • SIGNIFICANT GROWTH IN THE SECOND HALF (+43.5% COMPARED TO THE FIRST HALF) THANKS TO THE STRONG SALES RECOVERY, DESPITE THE SECOND WAVE OF THE PANDEMIC CORE REVENUES3 AT € 1,876 MILLION IN THE SECOND HALF, + 5.9% H/H OPERATING EXPENSES AT € 1,181 MILLION IN THE SECOND HALF, -5.4% H/H THE EXCELLENT OPERATING RESULTS MADE IT POSSIBLE TO SUPPORT: 1 Result net of non-recurring components detailed in point 6 of the explanatory notes of this press release. 2 Effective from the closure of the accounting period as at 31 December 2020, the reclassified income statement is presented in a format that shows the profit (loss) before tax from continuing operations, by excluding not only the accounting impacts relating to the PPA, amounting to € -41.5 million, and the change in the company's creditworthiness on certificate issues, amounting to € -11.7 million, but some extraordinary components involving a significant amount, which have a notable influence on the economic results of the periods being compared, preventing a full understanding of the actual operating performance. -
Retirement Strategy Fund 2060 Description Plan 3S DCP & JRA
Retirement Strategy Fund 2060 June 30, 2020 Note: Numbers may not always add up due to rounding. % Invested For Each Plan Description Plan 3s DCP & JRA ACTIVIA PROPERTIES INC REIT 0.0137% 0.0137% AEON REIT INVESTMENT CORP REIT 0.0195% 0.0195% ALEXANDER + BALDWIN INC REIT 0.0118% 0.0118% ALEXANDRIA REAL ESTATE EQUIT REIT USD.01 0.0585% 0.0585% ALLIANCEBERNSTEIN GOVT STIF SSC FUND 64BA AGIS 587 0.0329% 0.0329% ALLIED PROPERTIES REAL ESTAT REIT 0.0219% 0.0219% AMERICAN CAMPUS COMMUNITIES REIT USD.01 0.0277% 0.0277% AMERICAN HOMES 4 RENT A REIT USD.01 0.0396% 0.0396% AMERICOLD REALTY TRUST REIT USD.01 0.0427% 0.0427% ARMADA HOFFLER PROPERTIES IN REIT USD.01 0.0124% 0.0124% AROUNDTOWN SA COMMON STOCK EUR.01 0.0248% 0.0248% ASSURA PLC REIT GBP.1 0.0319% 0.0319% AUSTRALIAN DOLLAR 0.0061% 0.0061% AZRIELI GROUP LTD COMMON STOCK ILS.1 0.0101% 0.0101% BLUEROCK RESIDENTIAL GROWTH REIT USD.01 0.0102% 0.0102% BOSTON PROPERTIES INC REIT USD.01 0.0580% 0.0580% BRAZILIAN REAL 0.0000% 0.0000% BRIXMOR PROPERTY GROUP INC REIT USD.01 0.0418% 0.0418% CA IMMOBILIEN ANLAGEN AG COMMON STOCK 0.0191% 0.0191% CAMDEN PROPERTY TRUST REIT USD.01 0.0394% 0.0394% CANADIAN DOLLAR 0.0005% 0.0005% CAPITALAND COMMERCIAL TRUST REIT 0.0228% 0.0228% CIFI HOLDINGS GROUP CO LTD COMMON STOCK HKD.1 0.0105% 0.0105% CITY DEVELOPMENTS LTD COMMON STOCK 0.0129% 0.0129% CK ASSET HOLDINGS LTD COMMON STOCK HKD1.0 0.0378% 0.0378% COMFORIA RESIDENTIAL REIT IN REIT 0.0328% 0.0328% COUSINS PROPERTIES INC REIT USD1.0 0.0403% 0.0403% CUBESMART REIT USD.01 0.0359% 0.0359% DAIWA OFFICE INVESTMENT -
Welcome to the Governance Institute's E
Volume 11, No. 5, September 2014 Welcome to The Governance Institute’s E-Briefings! This newsletter is designed to inform you about new research and expert opinions in the area of hospital and health system governance, as well as to update you on services and events at The Governance Institute. Please note that you are receiving this newsletter because you are a Governance Institute member or expressed interest at one of our conferences. The Rise of the Hospital Joint Venture By Barry Sagraves, Juniper Advisory, and Ken Marlow, Waller This article is the first in a series examining the advantages of joint ventures, the process of developing a joint venture, and expected trends related to these transactions. Since the enactment of the Affordable Care Act in partners that complement and enhance its 2010, more and more hospitals and health systems operations, capitalization, compliance, and quality have entered into some sort of affiliation, whether functions. Exploring a range of joint venture through acquisition, membership substitution, joint alternatives has been found by many systems to be venture, or clinical affiliation. This trend is a result a “best of both worlds” approach—combining the of the mounting pressures hospitals and health installed market presence and reputation of a non- systems face in the current healthcare profit system with the scale, access to capital, and environment. Yet, fundamental change in the management expertise of an investor-owned makeup of the hospital market also paves way for company. innovation, which includes new ways that organizations may partner to confront these Most hospital and health system boards are aware challenges. -
Employment Report
CAREER MANAGEMENT CENTER Employment Report “One of the most important things we do is to connect companies with the right individuals, groups and resources at Kellogg — students, faculty, alumni and the administration. That’s when we 2009 all realize the full value of creating and sustaining strong relationships.” Table of Contents 4 Class of 2009 Profile 5 Demographic Information: Class of 2009 5 Base Salary Acceptances by Work Experience 5 Base Salary Acceptances by Undergraduate Degree 5 Base Salary Acceptances by Age 5 Base Salary Acceptances by Gender 5 Base Salary Acceptances by Geographic Distribution 6 Major Industries Chosen by Graduates, 2005-2009 6 Class of 2009 Graduate Base Salary Acceptances by Industry 7 Major Functions Chosen by Graduates, 2005-2009 7 Class of 2009 Graduate Base Salary Acceptances by Function 8 Major Employers 9 Graduate Sign-On Bonus by Industry Group 9 Graduate Sign-On Bonus by Functional Group 10 Corporate Recruiters 11 Job Acceptances: Class of 2009 by Company 15 Job Acceptances: Class of 2009 by Student 15 Two-Year MBA & JD-MBA students 27 One-Year MBA students 29 MMM students 30 Part-Time MBA students 33 Major Industries Chosen by Summer Interns, 2005-2009 33 Class of 2010 Summer Intern Salary Acceptances by Industry 34 Major Functions Chosen by Summer Interns, 2005-2009 34 Class of 2010 Summer Intern Salary Acceptances by Function 35 Major Summer Intern Employers 36 Summer Acceptances: Class of 2010 by Company 41 Summer Acceptances: Class of 2010 by Student 41 Two-Year MBA & JD-MBA students 54 MMM students 57 Kellogg Corporate Affiliates 58 Career Management Center Staff The power of collaboration Cover quote: Roxanne Hori, Assistant Dean and Director, Career Management Center Kellogg School of Management 1 he Kellogg School of Management at Companies that sustain relationships with the Kellogg Northwestern University is well known for its School also benefit from other mutually rewarding emphasis on collaboration and teamwork inside opportunities and programs. -
Nexi S.P.A. Successfully Prices the Offer of €500 Million Senior Unsecured Equity-Linked Bonds Due 2027
NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT A PROSPECTUS AND NOT AN OFFER OF ANY SECURITIES IN ANY JURISDICTION, INCLUDING IN OR INTO THE UNITED STATES, SOUTH AFRICA, AUSTRALIA OR JAPAN. NEITHER THIS ANNOUNCEMENT NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF, OR BE RELIED UPON IN CONNECTION WITH, ANY OFFER OR COMMITMENT TO INVEST IN SUCH SECURITIES WHATSOEVER IN ANY JURISDICTION (SEE "IMPORTANT NOTICE" BELOW). THE BONDS MAY NOT BE OFFERED OR SOLD TO RETAIL INVESTORS IN THE EUROPEAN ECONOMIC AREA, THE UNITED KINGDOM OR ELSEWHERE. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. Nexi S.p.A. successfully prices the offer of €500 million senior unsecured equity-linked Bonds due 2027 Milan, 17 April 2020 – Nexi S.p.A., a società per azioni incorporated under the laws of Italy ("Nexi" or the "Issuer"), has successfully priced its offering of €500 million ("Offering") of senior unsecured equity-linked bonds due 2027 (the "Bonds"). This bond issue, the largest equity-linked placement on the Italian market since 2017, allows Nexi to extend the average life of its debt, lower its average cost and further strengthens its liquidity position, also considering the planned acquisition of the merchant acquiring activities of the Intesa Sanpaolo Group, announced in December 2019. The Bonds will pay a coupon of 1.75% per annum, payable semi-annually in arrear. The conversion price will be €19.47, a premium of 50% above the Reference Share Price of €12.98, which is equal to the placement price of the Ordinary Shares in the Concurrent Equity Offering (as defined and further described below). -
AR UBS (Lux) Strategy Sicav EN.Indd
Asset management ab UBS Funds Annual Report 2019/2020 Investment Company under Luxembourg Law (SICAV) R.C.S. Luxembourg N° B 43 925 Annual report and audited financial statements as of 31 May 2020 UBS (Lux) Strategy SICAV UBS (Lux) Strategy SICAV UBS (Lux) Strategy SICAV – Dynamic Income (USD) – Systematic Allocation Portfolio Defensive Classic (USD) UBS (Lux) Strategy SICAV – Fixed Income (CHF) UBS (Lux) Strategy SICAV UBS (Lux) Strategy SICAV – Fixed Income (EUR) – Systematic Allocation Portfolio Dynamic (USD) UBS (Lux) Strategy SICAV – Fixed Income (USD) UBS (Lux) Strategy SICAV UBS (Lux) Strategy SICAV – Income (CHF) – Systematic Allocation Portfolio Medium (USD) UBS (Lux) Strategy SICAV – Income (EUR) UBS (Lux) Strategy SICAV UBS (Lux) Strategy SICAV – Income (USD) – Systematic Allocation Portfolio Medium Classic (USD) UBS (Lux) Strategy SICAV UBS (Lux) Strategy SICAV – Xtra Balanced (EUR) – Systematic Allocation Portfolio Defensive (USD) UBS (Lux) Strategy SICAV – Xtra Yield (EUR) Annual report and audited financial statements as of 31 May 2020 Table of contents Page ISIN Management and Administration 3 Features of the Company 5 Audit report 10 UBS (Lux) Strategy SICAV 13 UBS (Lux) Strategy SICAV – Dynamic Income (USD) 15 K-1-acc LU1917361336 K-1-mdist LU1917361419 (HKD) K-1-mdist LU1917362060 P-acc LU1917362490 P-mdist LU1917361179 (HKD) P-mdist LU1917361765 (SGD hedged) P-mdist LU1919997111 Q-acc LU1917360957 (HKD) Q-acc LU1917361682 Q-mdist LU1917361252 (HKD) Q-mdist LU1917361849 (SGD hedged) Q-mdist LU1919997202 UBS (Lux) Strategy -
April 12Th 2021 Cleansing Statement
NEXI S.P.A. Corso Sempione 55 20149, Milan Italy PRESS RELEASE Milan (Italy)—April 12, 2021 Nexi S.p.A., a società per azioni incorporated under the laws of Italy (“Nexi” or the “Issuer”), announced today that it it intends to offer approximately €2,100 million in aggregate principal amount of unsecured Senior Notes consisting of Senior Notes due 2026 and Senior Notes due 2029 (collectively, the “Notes”). In connection with the offering of the Notes, the Issuer disclosed certain information, including certain pro forma financial information and non-GAAP financial information of the Issuer, Nets Topco 2 S.à r.l. and its subsidiaries and SIA S.p.A. and its subsidiaries as of and for the years ended December 31, 2020 and 2019, to prospective holders of the Notes. A copy of such information is hereby disclosed to the Issuer’s shareholders and to the holders of the Issuer’s existing indebtedness and is attached hereto as Exhibit A (the “Information Release”). The Notes will be offered only to non-U.S. persons outside the United States in connection with offshore transactions complying with Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”). The Notes have not been registered under the Securities Act, or the securities laws of any state or other jurisdiction, and may not be offered or sold in the United States without registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities or blue sky laws and foreign securities laws. **************** This announcement contains information that prior to its disclosure may have constituted inside information under European Union Regulation 596/2014 on market abuse. -
9 Ottobre, 2019 Nexi Spa, Una Società Per Azioni Di Diritto Italiano
NEXI S.P.A. Corso Sempione 55 20149, Milano CLEANSING STATEMENT Milano — 9 ottobre, 2019 Nexi S.p.A., una società per azioni di diritto italiano (“Nexi” o la “Società”), ha annunciato oggi l’emissione di prestiti obbligazionari “Senior Notes”, in una o piú tranche, di importo pari a €825.000.000 con scadenza 2024 e/o 2027 (le “Notes”). Nel corso dell’emissione, la Società ha divulgato informazioni a potenziali acquirenti, inclusi dati finanziari pro forma e informazioni finanziarie non-GAAP per l’esercizio finanziario della Società al 31 dicembre 2018 e per i sei mesi al 30 giugno 2018 e 2019. Si divulgano con la presente dette informationi agli azionisti e ai detentori dei prestiti obbligazionari “Senior Secured Fixed Rate Notes” di importo pari a Euro 825.000.000, con cedola semestrale a tasso fisso del 4,125% p.a. e scadenza 1 novembre 2023 e se ne allega copia come Allegato A (l’“Information Release”). Le Notes sono destinate solamente a collocamento riservato ad investitori istituzionali che non siano “U.S. Persons” (come definite secondo la Regulation S dello Securities Act del 1933, come di volta in volta modificato, il “Securities Act”) e che si trovino al di fuori degli Stati Uniti ai sensi della Regulation S dello Securities Act. Le Notes non sono state soggetto a registrazione ai sensi del Securities Act o di altre leggi applicabili, e non possono essere offerte o acquistate negli Stati Uniti senza registrazione o senza una esenzione dai requisiti di registrazione conformemente al Securities Act e ad altre leggi applicabili. -
Cedacri Acquires OASI from Nexi
Cedacri acquires OASI from Nexi Milan, 22 January 2019 - Cedacri, a company in which FSI recently became a shareholder and joined the traditional bank partners, and Nexi announce the signing of an agreement for the acquisition of 100% of OASI S.p.A. (Outsourcing Applicativo e Servizi Innovativi) by Cedacri. OASI is the leader in Italy in software and integrated IT solutions for anti-money laundering and supervisory reporting used by banks, insurance companies and other financial institutions. The deal will allow Cedacri, through the integration of OASI's solutions, to further strengthen its leadership in the software and IT services market for financial institutions, as well as to continue its growth path. In particular, OASI will offer Cedacri the opportunity to: - Consolidate strategic assets and competencies in the areas of supervisory reporting and anti- money laundering; - Offer its IT solutions and services with high added value to OASI's extensive portfolio of customers; - Create industrial synergies. The agreement establishes that, at the effective date of the transaction, Cedacri will recognize Nexi a fee based on an Enterprise Value of € 151 million which must also take into account any adjustments deriving from the company's net financial position. The transaction closing is expected in February, following the completion of some formalities provided for in the agreement. The deal will be funded by Cedacri through a pool loan organized by a consortium of 14 financial institutions, shareholders and non-shareholders. Corrado Sciolla, CEO of Cedacri, commented on the deal: "I am sure that the acquisition of OASI will allow Cedacri to consolidate, through OASI, the leadership in the Reg-Tech market and to pursue further ambitious growth opportunities". -
Considering Quality in a Business Combination
Maximizing Value in Healthcare Mergers and Acquisitions Considering Quality in a Business Combination by Alexandra Normington, Juniper Advisory Of the umpteen elements hospital leaders evaluate when considering the viability of a potential partner, quality is generally at the top of the list. A larger partner can bring the scale, resources and expertise many smaller hospitals and systems seek to improve care quality for their community. This can include enhanced clinical protocols and standards, facility and equipment investments, deployment or recruitment of highly-skilled medical staff, patient support programs and more. Integrated delivery systems are also better positioned to address population health and health inequities, offering new approaches to keeping communities well and synergies with readmissions reduction strategies. A partnership can provide a host of opportunities to improve care quality and patient outcomes, but in the early stages of exploration there is limited ability to dive deep into tactics. Instead, hospital leaders look for succinct ways to ascertain a potential partner’s quality of care. Countless measures can be equated to quality, from objective metrics like infection and readmission rates, to the more subjective, like noise levels at night. And there is no shortage of options for comparison: CMS Hospital Compare, Leapfrog, Consumer Reports, US News & World Report, the Commonwealth Fund. Many states also have their own scorecards. These comparison tools attempt to distill complex hospital data into a single, consumer-friendly quality rating or grade. While these efforts are admirable in theory, health care organizations and trade groups regularly question rating systems’ methodologies, weighting and the impact of incomplete or statistically insignificant data. -
Nexi, Completed the Acquisition of the Merchant Acquiring Business by Intesa Sanpaolo
NEXI, COMPLETED THE ACQUISITION OF THE MERCHANT ACQUIRING BUSINESS BY INTESA SANPAOLO Further strengthened its PayTech role independent of Banks Milan, June 30th 2020 – Nexi S.p.A. ("Nexi" and, together with its subsidiaries, the "Nexi Group") announces today that it has completed the acquisition of the merchant acquiring business of Intesa Sanpaolo S.p.A. ("ISP") in execution of the agreements signed between the parties and announced on 19 December 2019. The acquisition has been successfully completed following the fulfilment of the conditions precedent provided for in those agreements, including the obtaining of authorizations from the Bank of Italy and the European Antitrust Authority. The transaction, which includes, as already communicated, a partnership of over 20 years with ISP for the marketing and distribution of Nexi Group products and the extension of the partnership already in place in issuing and ATM acquiring services, will generate an expected increase in the Group's EBITDA of approximately €95 million in 2020 and a high teens increase in EPS cash from 2020. As a result of this transaction, Nexi is consolidating its position in the merchant services world by increasing the operational scale of its merchant acquiring activities, while diversifying its revenues, and thereby driving and accelerating customer innovation. Nexi thus strengthens its PayTech role, independent leader in the development of digital payments in Italy in partnership with Banks. The consideration for the acquisition, equal to €1 billion, was financed through the proceeds from the issue of the equity-linked bond placed in April 2020 (maturity April 2027) and a term bank loan, granted today by a pool of banks, for a nominal amount of €466.5 million (maturity June 2025) which replaced the original €1 billion bridge loan (expiring at the end of 2021).